Chemoinformaics analysis of BETA-FARNESOL
Molecular Weight | 220.356 | nRot | 7 |
Heavy Atom Molecular Weight | 196.164 | nRig | 4 |
Exact Molecular Weight | 220.183 | nRing | 0 |
Solubility: LogS | -3.46 | nHRing | 0 |
Solubility: LogP | 4.827 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.431 |
Synth | 3.182 |
Natural Product Likeliness | 2.359 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.857 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.586 |
MDCK | 0.000013 |
BBB | 0.983 |
PPB | 0.808186 |
VDSS | 2.803 |
FU | 0.0883205 |
CYP1A2-inh | 0.431 |
CYP1A2-sub | 0.157 |
CYP2c19-inh | 0.126 |
CYP2c19-sub | 0.191 |
CYP2c9-inh | 0.056 |
CYP2c9-sub | 0.748 |
CYP2d6-inh | 0.064 |
CYP2d6-sub | 0.211 |
CYP3a4-inh | 0.136 |
CYP3a4-sub | 0.205 |
CL | 11.772 |
T12 | 0.265 |
hERG | 0.012 |
Ames | 0.028 |
ROA | 0.004 |
SkinSen | 0.962 |
Carcinogencity | 0.853 |
EI | 0.966 |
Respiratory | 0.434 |
NR-Aromatase | 0.019 |
Antiviral | Yes |
Prediction | 0.788842 |